Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies Limited has submitted its financial results for the quarter and nine months ended December 31, 2025 to the NSE. This is a routine regulatory filing confirming that the company's unaudited/a audited quarterly financial results have been shared with the exchange as required under listing rules. The actual financial figures, including revenue, profit, margins, and any auditor observations, would be contained in the attached results document.
No immediate price impact can be assessed from this submission notice alone; investors should review the attached detailed results for revenue, profit, margins, and any auditor remarks to gauge the company's performance and outlook.